Blackstone secures $1.6B so far for new life sciences fund targeted at $5B+
The world’s biggest alternative asset manager is further cementing itself in the life sciences industry with another fund dedicated to drug development.
Blackstone confirmed on …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.